This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q72347555
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в липні 1995 artículu científicu espublizáu en xunetu de 1995 scientific article published on 01 July 1995 wetenschappelijk artikel im Juli 1995 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q72347555-B54F8EFC-9B8A-4539-8ACF-1C36809B40AB
wdt:P577
1995-07-01T00:00:00Z
p:P2093
wds:Q72347555-B76DF79D-77F5-4D0F-9141-35F45EF00F50 wds:Q72347555-BCBAD738-DC6B-4014-9415-C569A64F1CFA wds:Q72347555-3D469466-0AB2-4655-BFAF-5F8DB74F09EA wds:Q72347555-32F9D552-36A9-499E-B6E0-1F47C43D8A1E wds:Q72347555-030EAB23-6FD5-45F3-8665-6E76BFA661C1 wds:Q72347555-8ECC5B95-DDF3-4ECB-8F46-3F343F325B45 wds:Q72347555-5867D457-D09E-4BDE-A900-C621DDCBA19D wds:Q72347555-49CE0DB0-C30E-4E5A-85E7-3F74A57CEADB wds:Q72347555-4CAD0E61-AA38-40F4-A10A-FF69C9BAF2F0
wdt:P2093
Koganty R Shang A Helling F Adluri S Calves M Yao TJ Longenecker BM Livingston PO Zhang S
rdfs:label
GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21 GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21
skos:prefLabel
GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21 GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21
schema:name
GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21 GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21
p:P50
wds:Q72347555-B403F62B-B63C-4C8D-9226-46D56A6EC4E0
wdt:P50
wd:Q108792642
p:P1476
wds:Q72347555-141829F1-78AB-4D67-B42C-A549D8755F29
wdt:P1476
GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21
p:P304
wds:Q72347555-0EF5668E-E2E8-4C63-9C9F-162A664AE7AE
wdt:P304
2783-2788
p:P31
wds:Q72347555-8C173D6D-0E58-4CCC-AEDD-21CE3E9C1A63
wdt:P31
wd:Q13442814
p:P921
wds:Q72347555-E9B38778-45D5-4211-A282-BBFF5C45472C
wdt:P921
wd:Q967453
p:P698
wds:Q72347555-3CEA1133-EA28-4A40-BEB6-4084B8291408
wdtn:P698
n11:7796403
wdt:P698
7796403
p:P1433
wds:Q72347555-D13DE01A-20D8-4C53-9428-7EB8A7AA2198
wdt:P1433
wd:Q326097
p:P433
wds:Q72347555-6B78E238-0B0D-4655-9804-7B499A375C5D
p:P478
wds:Q72347555-234EEF8A-670B-415A-BB02-586943CB7DDA
wdt:P433
13
wdt:P478
55